Axillary hyperhidrosis: a focused review

References

• Schick CH. Pathophysiology of hyperhidrosis. Thorac Surg Clin. 2016;26:389–93.
   PubMed Web of Science ®Google Scholar
• Hornberger J, Grimes K, Naumann M, et al. Multi-specialty working group on the recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51:274–86.
   PubMed Web of Science ®Google Scholar
• Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51:241–8.
   PubMed Web of Science ®Google Scholar
• Hamm H. Impact of hyperhidrosis on quality of life and its assessment. Dermatol Clin. 2014;32:467–76.
   PubMed Web of Science ®Google Scholar
• Doolittle J, Walker P, Mills T, et al. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308:743–9.
   PubMed Web of Science ®Google Scholar
• Leung AK, Chan PY, Choi MC. Hyperhidrosis. Int J Dermatol. 1999;38:561.
   PubMed Web of Science ®Google Scholar
• Walling HW. Primary hyperhidrosis increases the risk of cutaneous infection: a case-control study of 387 patients. J Am Acad Dermatol. 2009;61:242–6.
   PubMed Web of Science ®Google Scholar
• Lonsdale-Eccles A, Leonard N, Lawrence C. Axillary hyperhidrosis: eccrine or apocrine? Clin Exp Dermatol. 2003;28:2–7.
   PubMed Web of Science ®Google Scholar
• Hamm H, Naumann MK, Kowalski JW, et al. Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology (Basel). 2006;212:343–53.
   PubMed Web of Science ®Google Scholar
• Beer K, Oakley H. Axillary chromhidrosis: report of a case, review of the literature and treatment considerations. J Cosmet Dermatol. 2010;9:318–20.
   PubMed Web of Science ®Google Scholar
• Barankin B, Alanen K, Ting PT, et al. Bilateral facial apocrine chromhidrosis. J Drugs Dermatol. 2004;3:184–6.
   PubMedGoogle Scholar
• Griffith JR. Isolated areolar apocrine chromhidrosis. Pediatrics. 2005;115:e239–41.
   PubMed Web of Science ®Google Scholar
• Bang YH, Kim JH, Paik SW, et al. Histopathology of apocrine bromhidrosis. Plast Reconstr Surg. 1996;98:288–92.
   PubMed Web of Science ®Google Scholar
• Kanlayavattanakul M, Lourith N. Body malodours and their topical treatment agents. Int J Cosmet Sci. 2011;33:298–311.
   PubMed Web of Science ®Google Scholar
• Semkova K, Gergovska M, Kazandjieva J, et al. Hyperhidrosis, bromhidrosis, and chromhidrosis: fold (intertriginous) dermatoses. Clin Dermatol. 2015;33:483–91.
   PubMed Web of Science ®Google Scholar
• Greenberg JL, Shaw AM, Reuman L, et al. Clinical features of olfactory reference syndrome: an Internet-based study. J Psychosom Res. 2016;80:11–16.
   PubMed Web of Science ®Google Scholar
• Sato K, Kang WH, Saga KK, et al. Biology of sweat glands and their disorders II: disorders of sweat gland function. J Am Acad Dermatol. 1989;20:713–26.
   PubMed Web of Science ®Google Scholar
• Bovell DL, Clunes MT, Elder HY, et al. Ultrastructure of the hyperhidrotic eccrine sweat gland. Br J Dermatol. 2001;145:298–301.
   PubMed Web of Science ®Google Scholar
• Bovell DL, Corbett AD, Holmes S, et al. The absence of apoeccrine glands in the human axilla has disease pathogenetic implications, including axillary hyperhidrosis. Br J Dermatol. 2007;156:1278–86.
   PubMed Web of Science ®Google Scholar
• Noppen M, Sevens C, Gerlo E, et al. Plasma catecholamine concentrations in essential hyperhidrosis and effects of thoracoscopic D2–D3 sympathicolysis. Eur J Clin Invest. 1997;27:202–5.
   PubMed Web of Science ®Google Scholar
• Claes G, Gothberg G, Drott C. Endoscopic electrocautery of the thoracic sympathetic chain. A minimally invasive way to treat palmar hyperhidrosis. Scand J Plast Reconstr Surg Hand Surg. 1993;27:29–33.
   PubMed Web of Science ®Google Scholar
• Lin TS, Fang HY. Transthoracic endoscopic sympathectomy in the treatment of hyperhidrosis—with emphasis on perioperative management (1360 case analyses). Surg Neurol. 1999;52:453–7.
   PubMed Web of Science ®Google Scholar
• Herbst F, Plas E, Fugger R, et al. Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbs. A critical analysis and long-term results of 480 operations. Ann Surg. 1994;220:86–90.
   PubMed Web of Science ®Google Scholar
• Ro KM, Cantor RM, Lange KL, et al. Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg. 2002;35:382–6.
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Saadia D, Polin C, et al. Primary hyperhidrosis-evidence for autosomal dominant inheritance. Clin Auton Res. 2003;13:96–8.
   PubMed Web of Science ®Google Scholar
• Chen J, Lin M, Chen X, et al. A novel locus for primary focal hyperhidrosis mapped on chromosome 2q31.1. Br J Dermatol. 2015;172:1150–3.
   PubMed Web of Science ®Google Scholar
• Higashimoto I, Yoshiura K, Hirakawa N, et al. Primary palmar hyperhidrosis locus maps to 14q11.2-q13. Am J Med Genet A. 2006;140:567–72.
   PubMed Web of Science ®Google Scholar
• Stashak AB, Brewer JD. Management of hyperhidrosis. Clin Cosmet Investig Dermatol. 2014;7:285–99.
   PubMedGoogle Scholar
• Grabell DA, Hebert AA. Current and emerging medical therapies for primary hyperhidrosis. Dermatol Ther (Heidelb). 2017;7:25–36.
   PubMed Web of Science ®Google Scholar
• Scholes KT, Crow KD, Ellis JP, et al. Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate. Br Med J. 1978;2:84.
   PubMed Web of Science ®Google Scholar
• Pariser DM, Ballard A. Topical therapies in hyperhidrosis care. Dermatol Clin. 2014;32:485–90.
   PubMed Web of Science ®Google Scholar
• Arndt KA. Formulary. In Hsu JTS, ed. Manual of Dermatologic Therapeutics. Philadelphia: Lippincott Williams & Wilkins, 2007. p 291.
   Google Scholar
• Casey B, Kofinas P, Behrens A, et al. Blood Coagulation Inducing Polymer Hydrogel. Patent US20150030664, 3 June 2010. Available from https://www.google.com/patents/US20150030664.
   Google Scholar
• Innocenzi D, Lupi F, Bruni F, et al. Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial. Curr Med Res Opin. 2005;21:1949–53.
   PubMed Web of Science ®Google Scholar
• Innocenzi D, Ruggero A, Francesconi L, et al. An open-label tolerability and efficacy study of an aluminum sesquichlorohydrate topical foam in axillary and palmar primary hyperhidrosis. Dermatol Ther. 2008;21:S27–30.
   PubMed Web of Science ®Google Scholar
• Kim WO, Kil HK, Yoon KB, et al. Topical glycopyrrolate for patients with facial hyperhidrosis. Br J Dermatol. 2008;158:1094–7.
   PubMed Web of Science ®Google Scholar
• Mackenzie A, Burns C, Kavanagh G. Topical glycopyrrolate for axillary hyperhidrosis. Br J Dermatol. 2013;169:483–4.
   PubMed Web of Science ®Google Scholar
• Baker DM. Topical glycopyrrolate reduces axillary hyperhidrosis. J Eur Acad Dermatol Venereol. 2016;30:2131–6.
   PubMed Web of Science ®Google Scholar
• Nguyen NV. A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults. ClinicalTrials.gov. U.S. National Institutes of Health, 18 August 2016. Available from https://clinicaltrials.gov/ct2/show/NCT02633371.
   Google Scholar
• GlaxoSmithKline. Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis. ClinicalTrials.gov. U.S. National Institutes of Health, 21 July 2016. Available from https://clinicaltrials.gov/ct2/show/NCT02563899?term=hyperhidrosis&rank=19.
   Google Scholar
• Glaser DA, Galperin TA. Managing hyperhidrosis: emerging therapies. Dermatol Clin. 2014;32:549–53.
   PubMed Web of Science ®Google Scholar
• Glogau RG. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. Dermatol Surg. 2007;33:S76–S80.
   PubMed Web of Science ®Google Scholar
• Collins A, Nasir A. Topical botulinum toxin. J Clin Aesthet Dermatol. 2010;3:35–9.
   PubMedGoogle Scholar
• Kurta AO, Glaser DA. Emerging nonsurgical treatments for hyperhidrosis. Thorac Surg Clin. 2016;26:395–402.
   PubMed Web of Science ®Google Scholar
• Cruddas L, Baker DM. Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review. J Eur Acad Dermatol Venereol. 2016. [Epub ahead of print]. doi: 10.1111/jdv.14081.
   PubMed Web of Science ®Google Scholar
• Walling HW. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine. J Am Acad Dermatol. 2012;66:387–92.
   PubMed Web of Science ®Google Scholar
• Wolosker N, de Campos JR, Kauffman P, et al. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg. 2012;55:1696–700.
   PubMed Web of Science ®Google Scholar
• Glaser DA. Oral medications. Dermatol Clin. 2014;32:527–32.
   PubMed Web of Science ®Google Scholar
• Teivelis MP, Wolosker N, Krutman M, et al. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin. Clinics (San Paolo). 2014;69:608–14.
   PubMed Web of Science ®Google Scholar
• Schollhammer M, Brenaut E, Menard-Andivot N, et al. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial. Br J Dermatol. 2015;173:1163–8.
   PubMed Web of Science ®Google Scholar
• Lee HH, Kim DW, Kim DW, et al. Efficacy of glycopyrrolate in primary hyperhidrosis patients. Korean J Pain. 2012;25:28.
   PubMedGoogle Scholar
• Paller AS, Shah PR, Silverio AM, et al. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis. J Am Acad Dermatol. 2012;67:918.
   PubMed Web of Science ®Google Scholar
• Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis. N Engl J Med. 2001;344:488–93.
   PubMed Web of Science ®Google Scholar
• Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: a randomised, parallel group, double blind, placebo controlled trial. BMJ. 2001;323:596–9.
   PubMed Web of Science ®Google Scholar
• Connolly M, de Berker D. Management of primary hyperhidrosis: a summary of the different treatment modalities. Am J Clin Dermatol. 2003;4:681–97.
   PubMed Web of Science ®Google Scholar
• Haider A, Solish N. Hyperhidrosis: an approach to diagnosis and management. Dermatol Nurs. 2004;16:515–17.
   PubMedGoogle Scholar
• Lowe N, Campanati A, Bodokh I, et al. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol. 2004;151:1115–22.
   PubMed Web of Science ®Google Scholar
• Naumann M, Hamm H. Treatment of axillary hyperhidrosis. Br J Surg. 2002;89:259–61.
   PubMed Web of Science ®Google Scholar
• Nasr MW, Jabbour SF, Haber RN, et al. Comparison of microwave ablation, botulinum toxin injection, and liposuction-curettage in the treatment of axillary hyperhidrosis: a systematic review. J Cosmet Laser Ther. 2017;19:36–42.
   PubMed Web of Science ®Google Scholar
• Baumann L, Slezinger A, Halem M, et al. Pilot study of the safety and efficacy of myobloc (Botulinum Toxin Type B) for treatment of axillary hyperhidrosis. Int J Dermatol. 2005;44:418–24.
   PubMed Web of Science ®Google Scholar
• Frasson E, Brigo F, Acler M, et al. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months. Arch Dermatol. 2011;147:122–3.
   PubMedGoogle Scholar
• An JS, Hyun Won C, Si Han J, et al. Comparison of OnabotulinumtoxinA and RimabotulinumtoxinB for the treatment of axillary hyperhidrosis. Dermatol Surg 2015;41:960–7.
   PubMed Web of Science ®Google Scholar
• Rajagopal R, Mallya NB. Comparative evaluation of botulinum toxin versus iontophoresis with topical aluminum chloride hexahydrate in treatment of palmar hyperhidrosis. Med J Armed Forces India 2014;70:247–52.
   PubMedGoogle Scholar
• Nagar R, Sengar SS. A simple user-made iontophoresis device for palmoplantar hyperhidrosis. J Cutan Aesthet Surg. 2016;9:32–3.
   PubMedGoogle Scholar
• Reinauer S, Neusser A, Schauf G, et al. Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis. Br J Dermatol. 1993;129:166.
   PubMed Web of Science ®Google Scholar
• Shen JL, Lin GS, Li WM. A new strategy of iontophoresis for hyperhidrosis. J Am Acad Dermatol. 1990;22:239–41.
   PubMed Web of Science ®Google Scholar
• Pariser DM, Ballard A. Iontophoresis for palmar and plantar hyperhidrosis. Dermatol Clin. 2014;32:491–4.
   PubMed Web of Science ®Google Scholar
• McAleer MA, Collins P. A study investigating patients’ experience of hospital and home iontophoresis for hyperhidrosis. J Dermatol Treat. 2014;25:342–4.
   PubMed Web of Science ®Google Scholar
• Goldman A, Wollina U. Subdermal Nd-YAG laser for axillary hyperhidrosis. Dermatol Surg. 2008;34:756–62.
   PubMed Web of Science ®Google Scholar
• Aydin F, Pancar GS, Senturk N, et al. Axillary hair removal with 1064-nm Nd:YAG laser increases sweat production. Clin Exp Dermatol. 2010;35:588–92.
   PubMed Web of Science ®Google Scholar
• Mordon S, Plot E. Laser lipolysis versus traditional liposuction for fat removal. Expert Rev Med Devices. 2009;6:677–88.
   PubMed Web of Science ®Google Scholar
• Mordon SR, Trelles MA, Leclere FM, et al. New treatment techniques for axillary hyperhidrosis. J Cosmet Laser Ther. 2014;16:230–5.
   PubMed Web of Science ®Google Scholar
• Maletic D, Maletic A, Vizintin Z. Laser assisted reduction of axillary hyperhidrosis (LARAH) – evaluation of success up to 24 months after the treatment. J Laser Health Acad. 2011;1:37–42.
   Google Scholar
• Leclère FM, Moreno-Moraga J, Alcolea JM, et al. Efficacy and safety of laser therapy on axillary hyperhidrosis after one year follow-up: a randomized blinded controlled trial. Lasers Surg Med. 2015;47:173–9.
   PubMed Web of Science ®Google Scholar
• Nestor MS, Park H. Safety and efficacy of micro-focused ultrasound plus visualization for the treatment of axillary hyperhidrosis. J Clin Aesthet Dermatol. 2014;7:14–21.
   PubMedGoogle Scholar
• Macedo O, Matayoshi L, Matsumoto L. The new ultrasound technology for hyperhidrosis treatment: two case reports. J Am Acad Dermatol. 2013;4:AB66.
   Google Scholar
• Salah M, Attia A. New topical photodynamic therapy for management of primary axillary hyperhidrosis: a single-blinded, placebo-controlled study. J Egypt Women Dermatol. 2011;8:36–42.
   Google Scholar
• Johnson JE, O'Shaughnessy KF, Kim S. Microwave thermolysis of sweat glands. Lasers Surg Med. 2012;44:20–5.
   PubMed Web of Science ®Google Scholar
• Glaser DA, Coleman WP 3rd, Fan LK, et al. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study. Dermatol Surg. 2012;38:185–91.
   PubMed Web of Science ®Google Scholar
• Hong HC, Lupin M, O’Shaughnessy KF. Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Dermatol Surg. 2012;38:728–35.
   PubMed Web of Science ®Google Scholar
• Suh DH, Lee SJ, Kim K, et al. Transient median and ulnar neuropathy associated with a microwave device for treating axillary hyperhidrosis. Dermatol Surg. 2014;40:482–5.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Chang KY, Suh DH, et al. The efficacy of a microwave device for treating axillary hyperhidrosis and osmidrosis in Asians: a preliminary study. J Cosmet Laser Ther. 2013;15:255–9.
   PubMed Web of Science ®Google Scholar
• Bergón-Sendín M, Pulido-Pérez A, Sáez-Martín LC, et al. Preliminary experience with transdermal oxybutynin patches for hyperhidrosis. Actas Dermosifiliogr. 2016;107:845–50.
   PubMed Web of Science ®Google Scholar
• van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release. 2012;161:645–55.
   PubMed Web of Science ®Google Scholar
• Abtahi-Naeini B, Fatemi Naeini F, Adibi N, et al. Quality of life in patients with primary axillary hyperhidrosis before and after treatment with fractionated microneedle radiofrequency. J Res Med Sci. 2015;20:631–5.
   PubMed Web of Science ®Google Scholar
• Singh S, Davis H, Wilson P. Axillary hyperhidrosis: a review of the extent of the problem and treatment modalities. Surgeon 2015;13:279–85.
   PubMed Web of Science ®Google Scholar
• Fatemi Naeini F, Abtahi-Naeini B, Pourazizi M, et al. Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: a Sham Control study. Australas J Dermatol. 2015;56:279–84.
   PubMed Web of Science ®Google Scholar
• Kim M, Shin JY, Lee J, et al. Efficacy of fractional microneedle radiofrequency device in the treatment of primary axillary hyperhidrosis: a pilot study. Dermatology. 2013;227:243–9.
   PubMed Web of Science ®Google Scholar
• Torrisi BM, Zarnitsyn V, Prausnitz MR, et al. Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin. J Control Release. 2013;165:146–52.
   PubMed Web of Science ®Google Scholar
• Cameron AE. Selecting the right patient for surgical treatment of hyperhidrosis. Thorac Surg Clin. 2016;26:403–6.
   PubMed Web of Science ®Google Scholar
• Bechara FG, Gambichler T, Bader A, et al. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage. J Am Acad Dermatol. 2007;57:207–12.
   PubMed Web of Science ®Google Scholar
• Darabaneanu S, Darabaneanu HA, Niederberger U, et al. Long-term efficacy of subcutaneous sweat gland suction curettage for axillary hyperhidrosis: a prospective gravimetrically controlled study. Dermatol Surg. 2008;34:1170–7.
   PubMed Web of Science ®Google Scholar
• Ibrahim O, Kakar R, Bolotin D, et al. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial. J Am Acad Dermatol. 2013;69:88.
   PubMed Web of Science ®Google Scholar
• Coleman WP. Liposuction for axillary hyperhidrosis. J Am Acad Dermatol. 2013;69:1062.
   PubMed Web of Science ®Google Scholar
• Lee M, Ryman W. Liposuction for axillary hyperhidrosis. Australas J Dermatol. 2005;46:76–9.
   PubMedGoogle Scholar
• Feldmeyer L, Bogdan I, Moser A, et al. Short- and long-term efficacy and mechanism of action of tumescent suction curettage for axillary hyperhidrosis. J Eur Acad Dermatol Venereol. 2015;29:1933–7.
   PubMed Web of Science ®Google Scholar
• Wollina U, Köstler E, Schönlebe J, et al. Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis. Dermatol Surg. 2008;34:709–16.
   PubMed Web of Science ®Google Scholar
• Doolabh N, Horswell S, Williams M, et al. Thoracoscopic sympathectomy for hyperhidrosis: indications and results. Ann Thorac Surg. 2004;77:410–14.
   PubMed Web of Science ®Google Scholar
• Gibbons JP, Nugent E, O'Donohoe N, et al. Experience with botulinum toxin therapy for axillary hyperhidrosis and comparison to modelled data for endoscopic thoracic sympathectomy – a quality of life and cost effectiveness analysis. Surgeon. 2016;14:260–4.
   PubMed Web of Science ®Google Scholar
• Gorenstein LA, Krasna MJ. Less common side effects of sympathetic surgery. Thorac Surg Clin. 2016;26:453–8.
   PubMed Web of Science ®Google Scholar
• Hashmonai M. The history of sympathetic surgery. Thorac Surg Clin. 2016;26:383–8.
   PubMed Web of Science ®Google Scholar
• Lawrence CM, Lonsdale Eccles AA. Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients. Br J Dermatol. 2006;155:115–18.
   PubMed Web of Science ®Google Scholar
• Bechara FG, Sand M, Hoffmann K, et al. Histological and clinical findings in different surgical strategies for focal axillary hyperhidrosis. Dermatol Surg. 2008;34:1001–9.
   PubMed Web of Science ®Google Scholar
• Hussain AB, Holme SA, Kavanagh GM. Shelley procedure in axillary hyperhidrosis. Clin Exp Dermatol. 2016;41:229–31.
   PubMed Web of Science ®Google Scholar
• He J, Wang T, Dong J. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with botulinum toxin A. J Dermatol Treat. 2012;23:461–4.
   PubMed Web of Science ®Google Scholar
• Jung SK, Jang HW, Kim HJ, et al. A prospective, long-term follow-up study of 1,444 nm Nd:YAG laser: a new modality for treating axillary bromhidrosis. Ann Dermatol. 2014;26:184–8.
   PubMed Web of Science ®Google Scholar
• Lee KG, Kim SA, Yi SM, et al. Subdermal coagulation treatment of axillary bromhidrosis by 1,444 nm Nd:YAG laser: a comparison with surgical treatment. Ann Dermatol. 2014;26:99–102.
   PubMed Web of Science ®Google Scholar
• Kim IH, Seo SL, Oh CH. Minimally invasive surgery for axillary osmidrosis: combined operation with CO2 laser and subcutaneous tissue remover. Dermatol Surg. 1999;25:875–9.
   PubMed Web of Science ®Google Scholar
• Marks Jr JG. Treatment of apocrine chromhidrosis with topical capsaicin. J Am Acad Dermatol. 1989;21:418–20.
   PubMed Web of Science ®Google Scholar
• Matarasso SL. Treatment of facial chromhidrosis with botulinum toxin type A. J Am Acad Dermatol. 2005;52:89–91.
   PubMed Web of Science ®Google Scholar
• Wu JM, Mamelak AJ, Nussbaum R, et al. Botulinum toxin A in the treatment of chromhidrosis. Dermatol Surg. 2005;31:963–5.
   PubMed Web of Science ®Google Scholar